Molecular Af Oil
FDA Label NDC 76348-401

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Renu Laboratories, Llc for the product Molecular Af (NDC 76348-401). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding otc - active ingredient, warnings, otc - purpose, otc - keep out of reach of children, dosage & administration, indications & usage, inactive ingredient, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Otc - Active Ingredient

Tolnaftate 1%

Warnings

For External use only

Do not use on children under 2 years of age unless directed by a doctor

When using this product avoid contact with the eyes

Stop use and ask a doctor if

  • irritation occurs
  • there is no improvement within 4 weeks
  • Keep out of reach of children.  If swallowed, get medical help or contact a Poison Control Center right away

Otc - Purpose

Directions:

  • clean the affected area and dry thoroughly
  • apply a thin layer over the affected area twice daily
    (morning and night)
  • supervise children in the use of this product
  • for athlete’s foot, pay special attention to the spaces
    between toes. Wear well-fitting, ventilated shoes, and
    change shoes and socks at least once daily
  • use daily for 4 weeks. If condition lasts longer, ask
    a doctor
  • to prevent athlete’s foot, apply to the feet once
    or twice daily
  • this product is not effective on the scalp or nails

Otc - Keep Out Of Reach Of Children

Keep out of reach of children.  If swallowed, get medical help or contact a Poison Control Center right away

Dosage & Administration

Enter section text here

Indications & Usage

Enter section text here

Inactive Ingredient

Enter section text here

* Please review the disclaimer below.